Fatal parvoviral infection in captive cougars (Puma concolor): lessons for improving preventive health in wildlife exhibits

Wangkun Cheng , Chang Cai , Changlin Deng , Yingjun Lv , Jie Cao , Yufeng Li , Meirong Li

Animal Diseases ›› 2026, Vol. 6 ›› Issue (1) : 6

PDF
Animal Diseases ›› 2026, Vol. 6 ›› Issue (1) :6 DOI: 10.1186/s44149-025-00215-5
Case Report
case-report

Fatal parvoviral infection in captive cougars (Puma concolor): lessons for improving preventive health in wildlife exhibits

Author information +
History +
PDF

Abstract

Feline panleukopenia virus (FPV) is a highly contagious parvovirus that causes acute gastroenteritis, leukopenia, and high mortality in felids. Although domestic cats are commonly vaccinated, FPV continues to threaten captive and wild felids because of its environmental stability, rapid progression, and potential antigenic drift. In June 2022, a one-year-old captive female cougar (Puma concolor) at Hongshan Forest Zoo, Nanjing, China, was found dead following a peracute course without prodromal signs. The animal had previously received a trivalent feline vaccine containing feline panleukopenia, herpesvirus, and calicivirus antigens. Postmortem examination revealed perianal fecal staining, oral discharge, pulmonary congestion with peripheral emphysema, a darkened liver, and intestinal mucosal sloughing with petechiae. Histopathology revealed crypt epithelial necrosis, mucosal sloughing, and lymphoid depletion, which was consistent with parvoviral enteritis. Fecal and intestinal samples tested positive for FPV according to the lateral-flow assay and PCR. Viral replication was confirmed in CRFK cells via indirect immunofluorescence, and FPV antigen was shown to be localized to the intestinal crypt epithelium via immunohistochemistry. VP2 gene sequencing (1,753 bp) revealed that the isolate clustered with field strains from domestic cats in Jiangsu and Shanghai, which share near-complete nucleotide identity but differ from the Felocell vaccine strain in three amino acid substitutions (A91S, I232V, and L562V), two of which lie in antigenic loops and may affect antigenicity. No further FPV cases were detected during or after the 14-day observation period, reflecting successful containment through disinfection, relocation, feral cat control, and movement restrictions. This represents the first confirmed fatal FPV infection in a captive cougar in China and highlights the potential for local spillover from domestic reservoirs. The case underscores the need for continuous molecular surveillance, vaccination evaluation, and One Health–based biosecurity to protect susceptible wildlife populations at the human–domestic–wildlife interface.

Keywords

Feline panleukopenia virus / Puma concolor / Captive wildlife / Parvoviral enteritis / Zoo biosecurity / One Health / Spillover / VP2 gene / Vaccine mismatch

Cite this article

Download citation ▾
Wangkun Cheng, Chang Cai, Changlin Deng, Yingjun Lv, Jie Cao, Yufeng Li, Meirong Li. Fatal parvoviral infection in captive cougars (Puma concolor): lessons for improving preventive health in wildlife exhibits. Animal Diseases, 2026, 6(1): 6 DOI:10.1186/s44149-025-00215-5

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Awad, R. A., Hassan, S. A., & Martens, B. 2019. Treatment of feline panleukopenia virus infection in naturally infected cats and its assessment. ournal of Biological Sciences, 19, 155–160. https://doi.org/10.3923/jbs.2019.155.160

[2]

Clancy, M. M. 2024. Vaccination of exotic mammals. MSD Veterinary Manual. https://www.msdvetmanual.com/exotic-and-laboratory-animals/vaccination-of-exotic-mammals/vaccination-of-exotic-mammals

[3]

DeTar, L. 2025. Feline panleukopenia. Merck Veterinary Manual. https://www.merckvetmanual.com/digestive-system/infectious-diseases-of-the-gastrointestinal-tract-in-small-animals/feline-panleukopenia

[4]

Fang N, Li M, Zhang A, Wen L, Li H, Ye X, Zhang F, Chen R. Cross-species characterization of feline parvovirus and feline-origin canine parvovirus Southern China (2023–2024): Insights into epidemiology, genetic evolution and recombination. Bmc Veterinary Research, 2025, 21(1): 583

[5]

Hu, C., Xue, H., Xie, J., Song, Y., Zhu, K., Ma, H., Fu, J., & Gao, X. 2023. Isolation and identification of feline panleukopenia virus strain YB-1 and analysis of its variability with vaccine strains (in Chinese). Chinese Journal of Preventive Veterinary Medicine, 6: 649–653. https://qikan.cqvip.com/Qikan/Article/Detail?id=7110715673&utm_source=chatgpt.com

[6]

Kolangath SM, Upadhye SV, Dhoot VM, Pawshe MD, Bhadane BK, Gawande AP, Kolangath RM. Molecular investigation of feline panleukopenia in an endangered leopard ( Panthera pardus ) – a case report. Bmc Veterinary Research, 2023, 19156

[7]

Lane EP, Brettschneider H, Caldwell P, Oosthuizen A, Dalton DL, du Plessis L, Steyl J, Kotze A. Feline panleukopaenia virus in captive nondomestic felids in South Africa. Onderstepoort Journal of Veterinary Research, 2016, 831 a1099

[8]

Li J, Zeng Y, Peng J, Zhou Y, Li L, Wang Y, Ye Z, Chen Q, Yan Q, Li Q. Assessing immune evasion potential and vaccine suitability of a feline panleukopenia virus strain. Veterinary Vaccines, 2024, 32 100067

[9]

Minh H, Son NV, Duc HM, Lin C-N, Tyan Y-C, Chuang K-P. Genetic diversity and relatedness of feline parvovirus in Vietnam and its potential implications for canine-feline transmission. Archives of Virology, 2023, 1691 11

[10]

Punyapornwithaya V, Arjkumpa O, Buamithup N, Jainonthee C, Salvador R, Jampachaisri K. The impact of mass vaccination policy and control measures on lumpy skin disease cases in Thailand: Insights from a Bayesian structural time series analysis. Front Vet Sci, 2023, 10: 1301546

[11]

Rehme T, Hartmann K, Truyen U, Zablotski Y, Bergmann M. Feline panleukopenia outbreaks and risk factors in cats in animal shelters. Viruses, 2022, 146 1248

[12]

Sacristán, I., Esperón, F., Pérez, R., Acuña, F., Aguilar, E., García, S., López, M. J., Neves, E., Cabello, J., Hidalgo-Hermoso, et al. 2021. Epidemiology and molecular characterization of Carnivore protoparvovirus-1 infection in the wild felid Leopardus guigna in Chile. Transbound Emerg Dis, 68 (6): 3335–3348. https://doi.org/10.1111/tbed.13937

[13]

Sassa Y, Fukui D, Takeshi K, Miyazawa T. Neutralizing antibodies against feline parvoviruses in nondomestic felids inoculated with commercial inactivated polyvalent vaccines. The Journal of Veterinary Medical Science, 2006, 68111195-1198

[14]

Stuetzer B, Hartmann K. Feline parvovirus infection and associated diseases. The Veterinary Journal, 2014, 201(2): 150-155

[15]

Wei, J., Shi, Y., Wang, X., He, S., Qi, X., Lu, R., Gao, Y., Liu, Z., Wang, Y., Wu, Y. et al. 2024. The first outbreak of feline panleukopenia virus infection in captive Pallas’s cats in Xining Wildlife Park [Original Research]. Frontiers in Veterinary Science, 11 - 2024. https://doi.org/10.3389/fvets.2024.1418553

[16]

Wen Y, Tang Z, Wang K, Geng Z, Yang S, Guo J, Chen Y, Wang J, Fan Z, Chen Pet al.. Epidemiological and molecular investigation of feline panleukopenia virus infection in China. Viruses, 2024, 1612 1967

[17]

Zhang H, Zhang W, Pan Y, Li H, He T, Dong Q, Song W, Zhang W, Zhang L, Kareem K, Jiang S, Sheng J. Evolutionary dynamics and pathogenicity analysis of Feline Panleukopenia Virus in Xinjiang, China. Microorganisms, 2024, 1211 2205

RIGHTS & PERMISSIONS

The Author(s)

PDF

6

Accesses

0

Citation

Detail

Sections
Recommended

/